Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm O'Morain

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
American Journal of Human Genetics|March 5, 2002
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel diseaseSuzanne Lesage, Habib Zouali, Jean-Pierre Cézard, et al.
Helicobacter|April 15, 2026
Overview of Gastric Cancer Prevention Initiatives in EuropeMarcis Leja, Danute Ražuka-Ebela, Bojan Tepes, et al.
Gastroenterology|September 6, 2006
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluationSelwyn Odes, Hillel Vardi, Michael Friger, et al.
The Lancet. Gastroenterology & Hepatology|July 9, 2023
Difficult-to-treat inflammatory bowel disease: results from an international consensus meetingTommaso Lorenzo Parigi, Ferdinando D'Amico, Maria T Abreu, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013-2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Luis Bujanda, Olga P Nyssen, Dino Vaira, et al.
Journal of Clinical Medicine|June 24, 2022
Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of <i>Helicobacter</i><i>pylori</i> Infection (Hp-EuReg)Luis Fernández-Salazar, Ana Campillo, Luis Rodrigo, et al.
Journal of Crohn'S & Colitis|April 5, 2023
Reduced Serological Response to COVID-19 Booster Vaccine is Associated with Reduced B Cell Memory in Patients With Inflammatory Bowel Disease; VARIATION [VAriability in Response in IBD AgainsT SARS-COV-2 ImmunisatiON]Jayne Doherty, Neil O'Morain, Roisin Stack, et al.
European Journal of Human Genetics : EJHG|April 30, 2015
Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility lociCiara Coleman, Emma M Quinn, Anthony W Ryan, et al.
Scandinavian Journal of Gastroenterology|March 14, 2007
Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease courseFrank L Wolters, Catelijne Joling, Maurice G Russel, et al.
Journal of Crohn'S & Colitis|December 19, 2023
Outcomes and Endpoints of Postoperative Recurrence in Crohn's Disease: Systematic Review and Consensus ConferenceNassim Hammoudi, David Sachar, Geert D'Haens, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
American Journal of Human Genetics|March 5, 2002
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel diseaseSuzanne Lesage, Habib Zouali, Jean-Pierre Cézard, et al.
Helicobacter|April 15, 2026
Overview of Gastric Cancer Prevention Initiatives in EuropeMarcis Leja, Danute Ražuka-Ebela, Bojan Tepes, et al.
Gastroenterology|September 6, 2006
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluationSelwyn Odes, Hillel Vardi, Michael Friger, et al.
The Lancet. Gastroenterology & Hepatology|July 9, 2023
Difficult-to-treat inflammatory bowel disease: results from an international consensus meetingTommaso Lorenzo Parigi, Ferdinando D'Amico, Maria T Abreu, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013-2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Luis Bujanda, Olga P Nyssen, Dino Vaira, et al.
Journal of Clinical Medicine|June 24, 2022
Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of <i>Helicobacter</i><i>pylori</i> Infection (Hp-EuReg)Luis Fernández-Salazar, Ana Campillo, Luis Rodrigo, et al.
Journal of Crohn'S & Colitis|April 5, 2023
Reduced Serological Response to COVID-19 Booster Vaccine is Associated with Reduced B Cell Memory in Patients With Inflammatory Bowel Disease; VARIATION [VAriability in Response in IBD AgainsT SARS-COV-2 ImmunisatiON]Jayne Doherty, Neil O'Morain, Roisin Stack, et al.
European Journal of Human Genetics : EJHG|April 30, 2015
Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility lociCiara Coleman, Emma M Quinn, Anthony W Ryan, et al.
Scandinavian Journal of Gastroenterology|March 14, 2007
Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease courseFrank L Wolters, Catelijne Joling, Maurice G Russel, et al.
Journal of Crohn'S & Colitis|December 19, 2023
Outcomes and Endpoints of Postoperative Recurrence in Crohn's Disease: Systematic Review and Consensus ConferenceNassim Hammoudi, David Sachar, Geert D'Haens, et al.
Pageof 15